New technology for benign prostatic hyperplasia treatment with water vapor
Bumrungrad performed the latest minimally invasive procedure by water vapor therapy for Benign Prostatic Hyperplasia for the first time in Thailand.
At present, the number of the elderly has been rising, which raises health concerns among international public health organizations.
One of the most common health problems in older males is Benign Prostatic Hyperplasia (BPH), which is found in 50% of men 50 and over and 70% of men 60 and over.
The water vapor therapy for Benign Prostatic Hyperplasia (BPH) has been approved by the U.S. Food and Drug Administration (FDA) since 2015. It is also approved by the Thai Food and Drug Administration in early 2021.
Bumrungrad’s Urology Center, strives to provide accurate diagnosis and immediate, effective treatments which meet international safety standards.